JUSTIN TALLIS / AFP
Two shots of the Pfizer vaccine is highly effective against the new and rapidly spreading delta variant of COVID-19.
A study of 19,000 people from Public Health England, published Wednesday, found that both doses of either the Pfizer or AstraZeneca vaccines offer protection against symptoms from both the alpha and delta variants.
The Pfizer vaccine has a 93.7% effectiveness rate at preventing symptomatic alpha infections, and 88% for the delta variant.
Two doses of AstraZeneca are 74.5% effective at preventing alpha infections, and 67% for the delta variant.
However, the effectiveness of the vaccines takes a significant dive if the patient only receives one dose of either vaccine.
The study found both vaccine brands to be slightly more than 48% effective against the alpha variant and only about 30% effective against the delta variant if only one dose was administered.
Those who conducted the study suggest prioritizing second doses, especially in vulnerable populations, to prevent coronavirus outbreaks effectively.
More from International
Moderna's COVID-19 vaccine approved for children over 12
Europe's medicines regulator on Friday recommended approving the use of Moderna's COVID-19 vaccine in 12 to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the bloc.
Heavy rains kill dozens in India, many trapped in landslides
At least 18 people have died in the western Indian state of Maharashtra after torrential rainfall caused landslides and flooding that submerged low lying areas and cut off hundreds of villages.
Australia tightens Sydney lockdown in 'national emergency'
Australia's New South Wales state on Friday reported its biggest daily rise in new COVID-19 cases this year, prompting a tighter lockdown in Sydney in what state officials called a "national emergency".
Website outage impacts Amazon AWS, British Airways among others
Websites of several airlines, banks and technology companies, including Amazon's AWS, British Airways, Delta Air Lines and American Express, faced outages on Thursday.
China rejects WHO plan for study of COVID-19 origin
China rejected on Thursday a World Health Organisation plan for a second phase of an investigation into the origin of the coronavirus, which includes the hypothesis it could have escaped from a Chinese laboratory, a top health official said.